Table 4

Scope of databases
CATEGORY
 N (147)
 AHFS
 CP
 DIO
 DM
 EOF
 EOP
 FC
 IDI
 JHAG
 LC
 LC-AHFS
 MDR
 MM
 PPDC
Dosing
 15
 12
 11
 12
 10
 6
 6
 12
 12
 8
 12
 12
 12
 13
 6
Indication
 15
 13
 11
 11
 5
 6
 6
 9
 7
 11
 13
 13
 14
 15
 7
Adverse Reaction/Event
 13
 9
 12
 8
 10
 6
 6
 11
 11
 8
 8
 9
 9
 11
 4
Contraindications
 13
 12
 9
 10
 8
 8
 8
 9
 8
 5
 11
 12
 10
 12
 5
Drug-Drug Interactions
 12
 11
 12
 10
 10
 11
 11
 10
 10
 6
 10
 11
 12
 10
 10
Emerging Resistance
 12
 8
 9
 4
 10
 0
 0
 9
 10
 6
 2
 8
 9
 10
 0
Administration
 10
 10
 8
 8
 8
 6
 6
 10
 10
 7
 9
 10
 10
 9
 4
Mechanism of Action
 9
 8
 9
 8
 6
 8
 8
 9
 7
 7
 7
 8
 8
 7
 7
Food-Drug Interactions
 7
 7
 5
 4
 4
 2
 2
 4
 4
 3
 4
 7
 5
 4
 2
Compatibility/Stability
 7
 4
 4
 0
 3
 0
 0
 4
 4
 0
 3
 4
 5
 4
 0
Spectrum of Activity
 7
 5
 6
 4
 5
 3
 3
 5
 5
 6
 4
 5
 5
 7
 4
Pregnancy/Lactation
 7
 5
 7
 6
 5
 5
 5
 6
 6
 5
 5
 7
 6
 6
 5
Synergy
 6
 6
 5
 4
 5
 3
 3
 5
 4
 4
 3
 6
 6
 6
 3
Drug-Herb Interactions
 5
 2
 2
 1
 2
 0
 2
 1
 2
 1
 1
 2
 2
 3
 2
Cost
 5
 0
 0
 3
 0
 2
 2
 0
 0
 3
 2
 2
 3
 0
 0
Pharmacokinetics
 4
 3
 3
 3
 4
 1
 1
 4
 4
 2
 2
 3
 3
 4
 1
Percent Answered (%)
78
 77
 65
 65
 46
 47
 73
 71
 56
 65
 81
 81
 82
 41

N = number of questions; AHFS = American Hospital Formulary Service Drug Information; CP = Clinical Pharmacology; DIO = DIOne; DM = DailyMed; EOF = Epocrates Online Free; EOP = Epocrates Online Premium; FC = Facts & Comparisons 4.0 Online; IDI = Internet Drug Index; JHAG = Johns Hopkins ABX Guide; LC = Lexi-Comp; LC-AHFS = Lexi-Comp with American Hospital Formulary Service; MDR = Medscape Drug Reference; MM = Micromedex, PPDC = PEPID PDC

Polen et al. BMC Infectious Diseases 2008 8:153   doi:10.1186/1471-2334-8-153